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Abstract
Background: Ameloblastomas are rarely found in pregnant women, with only two cases reported in the scientific
literature. We report the first case of ameloblastoma in a pregnant woman in Brazil.
Case presentation: A 27-year-old white woman, 12-weeks pregnant, presented with a large mass in her right
posterior mandible. Panoramic radiography revealed a lesion involving her mandibular right first molar with
displacement of her mandibular right third molar and impairment of the mandibular bone base. The results of an
incisional biopsy led to a diagnosis of acanthomatous ameloblastoma. We fixed Erich arch bars to both dental
arches and performed an en-bloc resection surgery under general anesthesia for tumor removal. She was then
treated by maxillomandibular rigid fixation with the installation of a 2.7 mm non-locking reconstruction plate. So
far, she has presented no motor deficits, chewing difficulties, or relevant asymmetries. The tumor showed no
recurrence after the first year (pregnancy period) and post-surgery radiographic follow-up revealed a reduction in
the surgical area after osseous growth in the margins of the lesion. Although she displayed no systemic
comorbidities that affected pregnancy, the fetus was born with alobar holoprosencephaly.
Conclusions: The possible influence of pregnancy hormones on the growth and development of tumors in
general and ameloblastoma in particular, is still not explained in the literature. However, evidence reveals that the
issue should be further studied. Although en-bloc resection surgery is considered a radical method of treatment, it
is an effective alternative in ameloblastoma removal, presenting low rates of recurrence.
Keywords: Ameloblastoma, Pregnancy, Odontogenic tumors
Abbreviations: AOT, Adenomatoid odontogenic tumor; Bcl-2, B-cell lymphoma 2; CBCT, Cone beam computed
tomography; CT, Computed tomography; HRS, Hospital Regional de Sobradinho; rad, Absorbed radiation dose.
Background
Ameloblastoma is an aggressive infiltrating odontogenic
tumor with high recurrence rates. It represents 11 % of
all odontogenic tumors and less than 1 % of all tumors
affecting the jaws, with a rare ability to metastasize [1].
It is an asymptomatic slow-growing tumor characterized
by cortical bone expansion or perforation and infiltration
to soft tissues [2]. The disease commonly appears in the
third to seventh decades of life, with no gender prefer-
ence [3]. It mainly occurs in the mandibular bone (85 %
prevalence) with predilection for the posterior region of
the molars, on the ascending branch of the mandible.
Less frequent cases have been reported in the premolar
and anterior regions [4].
Ameloblastoma radiology usually presents a unilocular
or multilocular radiolucency; the latter has a soap bubble
appearance, indicating that it might be divided into sev-
eral bone spaces by trabeculae. Ameloblastomas are
often associated with the presence of unerupted teeth.
The teeth associated with ameloblastoma are vital, pre-
senting in some cases with migration, mobility, and root
resorption [3].
Surgical treatment for this type of tumor extends from
conservative forms, such as curettage, enucleation, and
cryosurgery, to more radical forms, such as marginal
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resection, en-bloc resection, or segmental/hemiresection
[5]. Recurrence rates vary according to the type of lesion
and surgical modality, ranging from 7 to 25 % [6, 7] after
radical surgery and 20 [7] to 33 % [4] for conservative
techniques.
Ameloblastoma cases during pregnancy are still scarce
in the literature. Here we present a rare clinical case of
ameloblastoma in a 27-year-old white pregnant woman,
the first case reported in the Brazilian population.
Case presentation
A descriptive case study conducted at Hospital Regional
de Sobradinho (HRS) after Federal District health ethics
committee approval (CEP/SESDF) on 3 August 2015,
CAAE - 47521015.6.0000.5553, number: 1,167,855.
These data were recorded in the free informed consent
form signed by the patient. The case was selected due to
the rarity of ameloblastoma occurrence in pregnant
women.
A 27-year-old white woman, 12-weeks pregnant, pre-
sented with increased mandibular volume in the right
posterior region of her mandible. She had been com-
plaining of pain and bleeding for months, feeling un-
comfortable on her face when sleeping on her right side.
She described initial observation of the pain in the mid-
dle of the second month of pregnancy. The pain in-
creased in the third month, which led her to search for
public dental care. She was observed until week 22 be-
cause surgery was recommended only after the first tri-
mester of pregnancy.
According to hospital records, she was a non-cigarette
smoking and non-alcoholic primipara reporting no rele-
vant systemic comorbidities. She had attended 16 pre-
natal appointments due to the diagnosis of alobar
holoprosencephaly at week 30 of pregnancy. She re-
ported no pregnancy complications and exhibited nor-
mal values in blood tests.
An intraoral examination showed mandibular/buccal
expansion in the right alveolar process, close to her mo-
lars, with deviation of her right mandibular third molar.
Mucosa was ulcerated and bleeding due to trauma
caused by the maxillary teeth cusps, which was the
source of the pain. She had had the right mandibular
second molar extracted on an unknown date due to ex-
tensive tooth decay and pain. Imaging examination of
the lesion region dating back to 2005 revealed no abnor-
malities from the surgery.
A panoramic X-ray showed a large unilocular osteo-
lytic lesion extending from her right mandibular first
molar to the ascending ramus. Images also showed dis-
placement of her right mandibular third molar and in-
volvement of the mandibular bone base (Fig. 1).
An incisional biopsy revealed acanthomatous amelo-
blastoma with nests of cords and islands of basaloid
odontogenic palisading epithelial cells. The columnar
cells showed elongated nuclei with inconspicuous nucle-
oli and exhibited inverted polarization opposite to the
basement membrane (Fig. 2a). The central area of the
islands consisted of loosely arranged cells resembling
stellate reticulum. These cells may exhibit squamous dif-
ferentiation, characterizing the acanthomatous histo-
logical variant (Fig. 2b).
She was admitted to our surgical center to be sub-
mitted to en-bloc resection surgery and fixation of a
reconstructive non-locking plate under general
anesthesia; during surgery she was in a supine pos-
ition, and she was monitored and pre-oxygenated.
Anesthesia was induced by rapid sequence of Sellick’s
maneuver with fentanyl 200 mg, propofol 150 mg,
Quelicin (succinylcholine) 60 mg and nasal intubation.
Maintenance was performed with oxygen, nitrous
oxide, and sevoflurane.
Surgical access was provided with Erich arch bar appli-
cations in both dental arches and through intramuscular
incision in the right cervical region. Prior to tumor
Fig. 1 Initial radiography with radiolucent image located at the right side of the ascending branch of the mandible
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removal, we adapted a 2.7 mm reconstructive non-
locking plate by boring holes in it. The plate was re-
moved and the maxillomandibular fixation was released
for intrasulcular incisions and gingiva detachment.
Osteotomy was performed from the mesial of her
second premolar to half of the ascending ramus.
Maxillomandibular fixation was redone and the 2.7
mm reconstructive non-locking plate was re-installed.
Extraoral suturing, fixation release and intraoral su-
turing were performed in sequence. At the end of the
surgery, we used elastics for occlusal maintenance.
We submitted the surgical specimen to a new histo-
pathological analysis, which confirmed the previous
diagnosis of ameloblastoma (Fig. 3).
She was then monitored for 24 months at the
Sobradinho Regional Hospital dental care unit, having
evolved well without any signs of recurrence. She pre-
sented no motor deficits, chewing difficulties, or rele-
vant asymmetries. She even reported improvement in
chin skin sensitivity. The tumor showed no recur-
rence after the first year (pregnancy period) and post-
surgery radiographic follow-up revealed a reduction of
surgical area after osseous growth in the margins of
the lesion. In the second year, radiography revealed a
suggestive image formation and osseous growth with-
out tumor recurrence (Fig. 4). Due to our patient’s
desire to become pregnant again, she decided to wait
for a second reconstructive stage.
Fig. 2 a Acanthomatous ameloblastoma: cords and network of odontogenic epithelium arranged in palisade exhibiting reversed polarity cores
(×400). b Acanthomatous ameloblastoma: cells with squamous differentiation can be observed in the center (×400)
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Discussion
The World Health Organization classifies ameloblas-
toma into three subtypes of odontogenic tumor: multi-
cystic, unicystic and peripheral [8]. Ameloblastoma is an
asymptomatic locally invasive slow-growing tumor
(benign) characterized by cortical bone expansion or
cortical perforation and infiltration to soft tissue. It is
regarded as a potentially malignant tumor. We re-
ported a case of unicystic subtype ameloblastoma.
Unicystic ameloblastomas affect younger patients, be-
tween the second and third decades of life, and are
often associated with impacted teeth, especially the
second and third molars [9, 10].
The clinical features most frequently associated with
unicystic ameloblastoma include swelling of the man-
dibular region and/or absence of a tooth from its
place in the arch in the region of the tumor [11].
Crepitation may occur depending on tumor volume.
Aspiration yields a yellow liquid, similar to
odontogenic cysts [12]. Cysts are generally painless
and hardly perceived by the patient in early stages.
Due to its slow growth, the tumor is generally tenta-
tively diagnosed through radiographic examination
[13, 14].
Some histological variants of ameloblastoma include
follicular, plexiform, granular cell, acanthomatous, basal
cell, and desmoplastic types [15]. Acanthomatous amelo-
blastoma is a rare variant of the disease exhibiting solid
epithelial cell nests with peripheral palisading ameloblas-
tic cells and central squamous cell differentiation. Due
to similar patterns, acanthomatous ameloblastoma may
be confused with a squamous cell carcinoma and may
also appear as a “hybrid” lesion of ameloblastoma
admixed with a pronounced desmoplastic pattern [16].
Ameloblastoma in the presented case follows the pat-
tern of other cases described in the literature. What
makes this case report relevant is the development of
ameloblastoma at week 12 of pregnancy. This fact
Fig. 3 Fragment of the mandible removed after surgery and submitted to confirm the initial biopsy
Fig. 4 Panoramic radiography at 24-month follow-up
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suggests that hormones released during pregnancy are
probably able to influence growth and development of
odontogenic tumors.
Because she was in her first trimester of pregnancy
when she came to our hospital dental service, computed
tomography (CT) was not recommended. A panoramic
radiography was done instead because a cone beam
computed tomography (CBCT) examination, which
could be used as a supplementary examination option, is
not available in the public health system. The use of
panoramic radiography represents a tenfold reduction in
the amount of radiation absorbed by the patient com-
pared to periapical radiography. For pregnant women,
since the intrauterine dose absorbed is less than 10-6
absorbed radiation dose (rad), the risk of mental abnor-
malities due to dental radiology is considered nonexis-
tent [17].
Fetal alobar holoprosencephaly, diagnosed after amelo-
blastoma removal, shows no connection with the sur-
gery. The condition is linked to chromosomal changes
such as Patau syndrome (trisomy 13) and Edwards syn-
drome (trisomy 18) [18]. Some studies also established a
relationship between diabetes and holoprosencephaly
[19]. Alobar holoprosencephaly accompanied by ceboce-
phaly is characterized by absent nose or single-nostril
flattened nose and closely set eyes. In the present case,
the baby died of pneumonia 10 months later.
Studies show conflicting results on the development of
odontogenic tumors during pregnancy. Sekiya et al. re-
ported a case of adenomatoid odontogenic tumor (AOT)
in which estrogen receptors (located in tumor cell nu-
clei) were positive for B-cell lymphoma 2 (Bcl-2), sug-
gesting that the survival of tumor cells was facilitated by
Bcl-2 upon continuous stimulation of estrogen during
pregnancy [20]. However, another study on AOT during
a pregnancy study by Bhandari and Kothan revealed
AOT with a cystic component with no dependence on
estrogen or progesterone for its growth [21].
Only two cases of ameloblastoma tumors during
pregnancy have been reported in the literature [22,
23]. Herberts and Sandstrom [22] showed that preg-
nancy hormones may influence the growth and devel-
opment of tumors. Estrogen and gonadotropin
(considered etiological agents of tumors), for example,
can induce hyperplasia because of their high concen-
tration levels during pregnancy.
Another study reported by Gordy et al. [23] sug-
gested that hormonal action modulates the lesion
during pregnancy, promoting rapid growth of the
ameloblastoma. Pregnancy hormones promote devel-
opment, growth, and birth of the newborn. These
hormones may stimulate the production of several
substances that, alone or in combination with each
other, encourage maternal benign or malignant tumor
lesion growth, although no confirmatory evidence of
that has yet been presented.
In the cases reported in the literature, the women
were 7-weeks [23] and 36-weeks [22] pregnant. Our
patient was in week 12 of her pregnancy. Apparently,
there is no specific period for the development of
ameloblastoma during pregnancy. As for the demo-
graphic details, one study reports the case of an
African-American patient [23] and another case does
not mention the ethnicity of the patient [22]. Our pa-
tient is white. Based on the available data, we can as-
sume that the disease has no racial preference,
although no cases of Asian patients have been re-
ported. Lesions were located in the jaw in both stud-
ies [23, 24], showing lingual expansion of the lower
molars [24] and expansion of buccal surface [23] in
the second premolar lower right region. This feature
can represent a preference for the mandibular posterior
region, similar to our findings. In both studies [23, 24],
erythema was not associated with the lesion and increased
mucous or swollen jaw were not identified. However, in
one case [24], the lesion was palpable, but presented no
fluctuation in its 5-year evolution period. In the other case
[23], the lesion was soft and fluctuating due to extraction
of the right mandibular second premolar 3 years before.
This difference can be explained by the evolution time of
the lesions before pregnancy, with or without cystic
degeneration.
Both studies [22, 23] considered conservative surgery
as the first surgical option before performing en-bloc re-
section. However, the physicians modified their treat-
ment plan, performing en-bloc resection initially due to
tumor growth, because there had been delay on the part
of the patient while she contemplated termination of
pregnancy [23], and lesion recurrence [22]. This empha-
sizes the need for the strict monitoring of patients in
order to prevent tumor complications due to a lack of
treatment during pregnancy.
In the case of not treating the ameloblastoma, the pa-
tient may run the risk of a pathologic fracture of the
lower jaw base [24], large lesions [24], difficulties in oc-
clusion, or recurrent trauma due to biting the lesion, in
addition to the displacement of structures such as the
tongue, floor of the mouth, or teeth, with the growth of
the lesion. However, unicystic ameloblastoma is less ag-
gressive with a better prognosis and reduced recurrence
rates in comparison to multicystic ameloblastoma, which
is locally invasive and highly destructive, because it tends
to infiltrate cancellous bone [25].
Acanthomatous-type ameloblastomas have a recurrence
rate of 16.2 %. Resection of unicystic ameloblastoma is de-
scribed to have the lowest recurrence rate (3.6 %) if bone
margins are removed appropriately. A conservative
method of treatment resulted in an 18 % recurrence rate.
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The aim of the conservative method is to reduce the size
of unicystic ameloblastoma; it is not a popular method,
but it is more beneficial for severely ill patients or those
with a huge lesion [11].
Regarding surgical risk, due to the fact that a unicystic
ameloblastoma has a lower recurrence rate and is less
aggressive, removal can be delayed. However, the possi-
bility of pathologic fracture of the jaw and increased
tumor volume were the main reasons we performed the
surgical procedure after our patient completed the first
trimester of pregnancy, when the maturation of the vital
structures of her fetus had already been completed.
Sevoflurane has excellent safety ratings, although there
are rare single case reports of severe acute liver injury
similar to halothane hepatitis, and it is the preferred
agent because it reduces mucous membrane irritation
[26]. Studies with animals failed to demonstrate risk to
the fetus and there are no controlled studies in pregnant
women [27].
Conclusions
The possible influence of pregnancy hormones on the
growth and development of tumors, particularly amelo-
blastoma, is not explained in the literature. However,
evidence suggests that the issue should be better ex-
plored by further studies. En-bloc resection surgery, al-
though a radical method of treatment, is an effective
alternative for ameloblastoma removal, presenting lower
recurrence rates.
Patient’s perspective
I write the following to provide assistance to the case re-
port written about my disease and care. I have no med-
ical or odontological knowledge, so I only write from my
own perspective and experience.
I sought the dental service that serves my community
because I started to feel uncomfortable on my face when
I slept on the right side. I was in the third month of
pregnancy and, fearing a toothache during that period, I
looked for a dentist. The dentist examined my mouth
and noticed something different on my face. One side
was slightly higher than the other. She asked my doctor’s
opinion about having a CT scan to identify the reason
for the growth. The doctor, however, said that since I
was pregnant, a CT scan was not suitable because of the
radiation. An X-ray was taken instead.
After the results of the examination-ray, the dentist
told me I had an injury on the bone of the right man-
dible and referred me to the center for dental specialties
at Sobradinho Regional Hospital for a consultation with
a specialist. The specialist dentist said it was an injury
involving the right side of my jaw and that surgery
would be necessary to remove it. He explained that the
lesion was large and it would be removed with a part of
the injured bone and teeth involved. After removal, he
would use a metal bar to join the ends. I was worried
about the procedure because I thought it could affect
my baby somehow. The dentist explained the risks of
not removing the lesion and told me what the best time
during pregnancy to do the procedure was. Pre-surgical
tests were done to check my health and I obtained
authorization from my prenatal doctor for the surgery.
The surgery was performed at the hospital’s surgical
center on 17 March 2014. I stayed in the hospital for a
day for observation and my bite was restrained for rapid
healing. The greatest difficulty after surgery was the in-
ability to eat solid food in the first few weeks. Another
thing that bothered me was sleeping because of the
post-surgical pain. After the surgery, I was accompanied
by the professionals who treated me and had no prob-
lems during pregnancy. I go to the dentist regularly for
routine screening to see if everything is still okay. The
scar was along the skin folds of my neck, so it does not
appear on my face.
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